Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Secondary Progressive Multiple Sclerosis
IRCT201210231584N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of imatinib in secondary-progressive multiple sclerosis (SPMS), sponsored by Tehran University of Medical Sciences. Started Nov 2012; status: completed.
02
Drugs
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on IRCT201210231584N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201210231584N3.